Cetera Investment Advisers Pa Vmed Inc. Transaction History

Cetera Investment Advisers

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.36 - $0.63 $1,080 - $1,890	3,000 Added 29.27%	13,250 $4,000
Q4 2022 Feb 14, 2023	BUY	$0.41 - $18.6 $4,202 - $190,650	10,250 New	10,250 $4,000
Q1 2022 May 13, 2022	SELL	$1.16 - $2.5 $14,499 - $31,250	-12,500 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.46 - $8.74 $22,140 - $78,660	-9,000 Reduced 41.86%	12,500 $31,000
Q3 2021 Nov 16, 2021	BUY	$5.1 - $9.39 $109,649 - $201,885	21,500 New	21,500 $184,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $93.7M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

Stay updated on Cetera Investment Advisers with notifications on news.